U., P., P., D., S., S., K., T., & N., C. (2017). Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand.
استشهاد بنمط شيكاغوU., Permsuwan, Dilokthornsaku P., Saokaew S., Thavorn K., و Chaiyakunapruk N. Cost-effectiveness of Dipeptidyl Peptidase-4 Inhibitor Monotherapy in Elderly Type 2 Diabetes Patients in Thailand. 2017.
MLA استشهادU., Permsuwan, et al. Cost-effectiveness of Dipeptidyl Peptidase-4 Inhibitor Monotherapy in Elderly Type 2 Diabetes Patients in Thailand. 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.